Guillermo Arreaza

1.8k total citations · 1 hit paper
35 papers, 1.5k citations indexed

About

Guillermo Arreaza is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, Guillermo Arreaza has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 16 papers in Immunology and 11 papers in Surgery. Recurrent topics in Guillermo Arreaza's work include Diabetes and associated disorders (23 papers), T-cell and B-cell Immunology (14 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Guillermo Arreaza is often cited by papers focused on Diabetes and associated disorders (23 papers), T-cell and B-cell Immunology (14 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Guillermo Arreaza collaborates with scholars based in Canada, United States and Japan. Guillermo Arreaza's co-authors include Mark J. Cameron, Terry L. Delovitch, Peter Zucker, T L Delovitch, Robert M. Strieter, Qing‐Sheng Mi, Stephen W. Chensue, Subrata Chakrabarti, Shayan Sharif and Craig Meagher and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Guillermo Arreaza

35 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

2001 512 citations Guillermo Arreaza, Peter Zucker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guillermo Arreaza Canada	18	1.0k	678	344	234	166	35	1.5k
Jean Leif United States	23	919 0.9×	586 0.9×	374 1.1×	148 0.6×	367 2.2×	44	1.7k
Balaji Balasa United States	17	770 0.7×	470 0.7×	239 0.7×	141 0.6×	225 1.4×	30	1.4k
Zhongsheng Sun China	8	829 0.8×	545 0.8×	204 0.6×	146 0.6×	243 1.5×	11	1.3k
Jo Harnaha United States	13	816 0.8×	255 0.4×	154 0.4×	103 0.4×	251 1.5×	25	1.1k
Yannick Simoni Singapore	16	822 0.8×	296 0.4×	181 0.5×	92 0.4×	275 1.7×	28	1.2k
H Vaughan Australia	13	414 0.4×	529 0.8×	770 2.2×	176 0.8×	376 2.3×	26	1.4k
Caroline Waltzinger France	20	1.9k 1.8×	425 0.6×	170 0.5×	85 0.4×	477 2.9×	38	2.4k
J Picard United Kingdom	14	605 0.6×	417 0.6×	404 1.2×	137 0.6×	385 2.3×	25	1.6k
Catherine Yin United States	13	968 0.9×	132 0.2×	233 0.7×	97 0.4×	348 2.1×	19	1.4k
Gaby Duinkerken Netherlands	25	728 0.7×	1.4k 2.0×	1.2k 3.5×	867 3.7×	229 1.4×	38	2.0k

Countries citing papers authored by Guillermo Arreaza

Since Specialization

Citations

This map shows the geographic impact of Guillermo Arreaza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Arreaza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Arreaza more than expected).

Fields of papers citing papers by Guillermo Arreaza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Arreaza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Arreaza. The network helps show where Guillermo Arreaza may publish in the future.

Co-authorship network of co-authors of Guillermo Arreaza

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Arreaza. A scholar is included among the top collaborators of Guillermo Arreaza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Arreaza. Guillermo Arreaza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meagher, Craig, Shayan Sharif, Shabbir Hussain, et al.. (2003). Cytokines and Chemokines in the Pathogenesis of Murine Type 1 Diabetes. Advances in experimental medicine and biology. 520. 133–158. 18 indexed citations

Arreaza, Guillermo, Konstantin V. Salojin, Wen Yang, et al.. (2003). Deficient activation and resistance to activation-induced apoptosis of cd8+ t cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clinical Immunology. 107(2). 103–115. 32 indexed citations

Sharif, Shayan, Guillermo Arreaza, Peter Zucker, & Terry L. Delovitch. (2002). Regulatory Natural Killer T Cells Protect against Spontaneous and Recurrent Type 1 Diabetes. Annals of the New York Academy of Sciences. 958(1). 77–88. 40 indexed citations

Sharif, Shayan, Guillermo Arreaza, Peter Zucker, Qing‐Sheng Mi, & Terry L. Delovitch. (2002). Regulation of autoimmune disease by natural killer T cells. Journal of Molecular Medicine. 80(5). 290–300. 50 indexed citations

Arreaza, Guillermo, et al.. (2001). The role of MIP-1alpha and MIP-1beta in adoptive transfer models of type 1 diabetes. The FASEB Journal. 15(4). 3577. 1 indexed citations

Arreaza, Guillermo, et al.. (2001). Role of Regulatory T Cells in the Pathogenesis of Autoimmune Diabetes. PubMed. 4. 308–332. 5 indexed citations

Cameron, Mark J., Craig A. Strathdee, Kevin D. Holmes, et al.. (2000). Biolistic-Mediated Interleukin 4 Gene Transfer Prevents the Onset of Type 1 Diabetes. Human Gene Therapy. 11(12). 1647–1656. 24 indexed citations

Bergerot, Isabelle, et al.. (1997). Role of T-cell anergy and suppression in susceptibility to IDDM. Research in Immunology. 148(5). 348–358. 14 indexed citations

Mukuta, Toshio, Guillermo Arreaza, Mitsushige Nishikawa, et al.. (1997). Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.. PubMed. 20(1). 5–15. 4 indexed citations

10.

Arreaza, Guillermo, Mark J. Cameron, Andrés Jaramillo, et al.. (1997). Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.. Journal of Clinical Investigation. 100(9). 2243–2253. 72 indexed citations

11.

Mukuta, Toshio, Mitsushige Nishikawa, Guillermo Arreaza, et al.. (1996). The Effect of Adding a Surfeit of Autologous CD8 ⁺ T Cells to SCID Mice after Secondary Rexenografts of Graves' Thyroid Tissue. Thyroid. 6(5). 429–436. 4 indexed citations

12.

Nishikawa, Mitsushige, Toshio Mukuta, Guillermo Arreaza, et al.. (1995). Effects of Monoclonal Antibody against CD45RB on Peripheral Blood Mononuclear Cell Proliferation and on HLA-DR and Adhesion Molecule Expression on Thyrocytes of Patients with Autoimmune Thyroid Disease. Thyroid. 5(4). 265–272. 3 indexed citations

13.

YOSHIKAWA, NORIO, Guillermo Arreaza, T. Morita, et al.. (1994). Studies of Human Peripheral Blood Mononuclear Cells (PBMC) from Patients with Subacute Thyroiditis in Severe Combined Immunodeficient (SCID) Mice: Less Production of Human Interferon Gamma than that Seen for Graves' Disease. Hormone and Metabolic Research. 26(9). 419–423. 3 indexed citations

14.

YOSHIKAWA, NORIO, Guillermo Arreaza, T. Morita, et al.. (1994). Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.. The Journal of Clinical Endocrinology & Metabolism. 78(2). 367–374. 19 indexed citations

15.

YOSHIKAWA, NORIO, Guillermo Arreaza, Toshio Mukuta, et al.. (1994). Studies of Human Thyroid Xenografts from Hashimoto's Thyroiditis in Severe Combined Immunodeficient (SCID) Mice: Detection of Thyroid Stimulation-Blocking Antibody. Thyroid. 4(1). 13–18. 1 indexed citations

16.

YOSHIKAWA, NORIO, Guillermo Arreaza, Toshio Mukuta, et al.. (1994). Effect of FK‐506 on xenografted human Graves' thyroid tissue in severe combined immunodeficient mice. Clinical Endocrinology. 41(1). 31–39. 4 indexed citations

17.

Resetkova, Erika, et al.. (1994). Seroreactivity to Bacterial Antigens Is Not a Unique Phenomenon in Patients with Autoimmune Thyroid Diseases in Canada. Thyroid. 4(3). 269–274. 16 indexed citations

18.

Resetkova, Erika, Guillermo Arreaza, NORIO YOSHIKAWA, et al.. (1993). Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD). Clinical & Experimental Immunology. 91(3). 397–403. 3 indexed citations

19.

Volpe, Robert J., T. Morita, NORIO YOSHIKAWA, et al.. (1993). New Animal Models for Human Autoimmune Thyroid Disease. Hormone and Metabolic Research. 25(12). 623–627. 15 indexed citations

20.

Volpe, Robert J., Yoshio Kasuga, Tetsuya Morita, et al.. (1993). The Use of the Severe Combined Immunodeficient Mouse and the Athymic "Nude" Mouse as Models for the Study of Human Autoimmune Thyroid Disease. Clinical Immunology and Immunopathology. 67(2). 93–99. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact